Logo
  • Home
  • Portfolio
  • About
  • News
Subscribe
Innocan Pharma (IPO) ๐ŸŽ‰
Innocan Pharma (IPO) ๐ŸŽ‰

Innocan Pharma (IPO) ๐ŸŽ‰

image
image

Innocan Pharma

InnoCan aims to harness the power of cannabinoids to target a wide variety of health problems. InnoCan plans to initially innovate new dermatology treatments, where research shows topical cannabinoid-combined treatments are highly effective. Innocan went public on the Canadian Stock Exchange in 2020.

Website: LINK

Founding Year: 2018

Investment Year: 2018

HQ Location: Tel Aviv ๐Ÿ‡ฎ๐Ÿ‡ฑ

Status: IPO ๐ŸŽ‰